IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 205 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $258,757 | +19.3% | 29,708 | +45.7% | 0.02% | -43.6% |
Q2 2023 | $216,886 | -17.4% | 20,384 | -18.3% | 0.04% | -20.4% |
Q1 2023 | $262,569 | -41.7% | 24,959 | -31.3% | 0.05% | -54.6% |
Q4 2022 | $450,092 | +210.4% | 36,327 | +159.8% | 0.11% | +227.3% |
Q3 2022 | $145,000 | -71.2% | 13,984 | -68.0% | 0.03% | -75.7% |
Q2 2022 | $504,000 | +130.1% | 43,693 | +132.2% | 0.14% | +81.3% |
Q4 2021 | $219,000 | -28.9% | 18,816 | -20.3% | 0.08% | -25.0% |
Q3 2021 | $308,000 | +96.2% | 23,616 | +94.1% | 0.10% | +53.8% |
Q2 2021 | $157,000 | +6.8% | 12,166 | -5.4% | 0.06% | -27.8% |
Q4 2020 | $147,000 | +22.5% | 12,866 | +10.2% | 0.09% | -40.8% |
Q2 2020 | $120,000 | -51.8% | 11,676 | -13.5% | 0.15% | -10.1% |
Q3 2018 | $249,000 | +1.6% | 13,500 | -6.1% | 0.17% | -73.3% |
Q1 2017 | $245,000 | -41.9% | 14,383 | -58.9% | 0.63% | +75.6% |
Q2 2015 | $422,000 | – | 34,980 | – | 0.36% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 16,390,000 | $191,107,000 | 16.54% |
HealthInvest Partners AB | 730,000 | $8,512,000 | 11.99% |
13D Management LLC | 612,853 | $7,146,000 | 2.74% |
Brown Capital Management | 16,257,899 | $189,567,000 | 1.57% |
BRIDGER MANAGEMENT, LLC | 929,714 | $10,840,000 | 1.40% |
Camber Capital Management LP | 3,000,000 | $34,980,000 | 1.20% |
Intrinsic Value Partners, LLC | 55,057 | $642,000 | 0.68% |
PRICE MICHAEL F | 520,000 | $6,063,000 | 0.67% |
CLARK ESTATES INC/NY | 355,000 | $4,139,000 | 0.61% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 8,145,674 | $94,979,000 | 0.56% |